Recent Events & Catalysts
Ionis Pharmaceuticals, Inc. (IONS) — real, dated facts. Not a claim about what caused any single day's price move.
Committee Signals
Proprietary signals generated by the Innellis AI committee — score changes, rating shifts, and analyst disagreements.
No committee signals recorded yet.
News
Rotation Away From Tech Lifts Moat Index In July
SeekingAlpha · today
Tracking Tweedy Browne Portfolio - Q2 2026 Update
SeekingAlpha · 2d ago
JP Morgan Maintains Overweight on Ionis Pharmaceuticals, Raises Price Target to $76
Benzinga · 8d ago
Alnylam Lowers 2026 Outlook As Second-Line Amvuttra Demand Normalizes, Stock Tanks
Benzinga · 12d ago
Wells Fargo Maintains Overweight on Ionis Pharmaceuticals, Lowers Price Target to $95
Benzinga · 12d ago
Microsoft To Rally More Than 40%? Here Are 10 Top Analyst Forecasts For Thursday
Benzinga · 12d ago
HC Wainwright & Co. Maintains Buy on Ionis Pharmaceuticals, Lowers Price Target to $115
Benzinga · 12d ago
Ionis Pharmaceuticals, Inc. 2026 Q2 - Results - Earnings Call Presentation
SeekingAlpha · 12d ago
SEC Filings (90 days)
Results of operations (earnings release), Financial statements and exhibits
Filed 2026-07-29 · 13d ago · Material
Regulation FD disclosure, Financial statements and exhibits
Filed 2026-07-10 · 32d ago
Regulation FD disclosure, Other events, Financial statements and exhibits
Filed 2026-07-09 · 33d ago
Regulation FD disclosure, Other events, Financial statements and exhibits
Filed 2026-06-24 · 48d ago
Other events, Financial statements and exhibits
Filed 2026-06-12 · 60d ago
Earnings
No recent earnings data available.
Latest Analyst Action
No recent analyst actions available.